It has been clear that the pathogenesis of DM is related to IFN-I, especially IFN-β, which is highly expressed in T cells in DM cutaneous lesions, and the IFN-I pathway is highly active in DM skin lesions (14). Here, IFNB1 is linked to dermatomyositis.